Vaxart, Inc.
VXRT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $82,413 | $103,222 | $92,765 | $150,809 |
| - Cash | $16,880 | $20,111 | $28,698 | $25,229 |
| + Debt | $15,444 | $16,113 | $20,561 | $23,284 |
| Enterprise Value | $80,977 | $99,224 | $84,628 | $148,864 |
| Revenue | $72,413 | $39,730 | $20,876 | $15,185 |
| % Growth | 82.3% | 90.3% | 37.5% | – |
| Gross Profit | $72,413 | $39,730 | $20,876 | $15,185 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$5,436 | -$12,097 | -$12,252 | -$8,649 |
| % Margin | -7.5% | -30.4% | -58.7% | -57% |
| Net Income | -$8,141 | -$14,986 | -$15,591 | -$11,985 |
| % Margin | -11.2% | -37.7% | -74.7% | -78.9% |
| EPS Diluted | -0.04 | -0.07 | -0.068 | -0.053 |
| % Growth | 42.9% | -2.3% | -30% | – |
| Operating Cash Flow | $2,595 | -$15,945 | -$9,599 | -$7,345 |
| Capital Expenditures | -$117 | $103 | -$130 | -$44 |
| Free Cash Flow | $2,478 | -$15,842 | -$9,729 | -$7,389 |